Bellevue Group AG - HARMONY BIOSCIENCES HLDGS IN ownership

HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 205 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of HARMONY BIOSCIENCES HLDGS IN
ValueSharesWeighting
Q1 2023$19,526,202
-40.6%
598,046
+0.3%
0.28%
-35.1%
Q4 2022$32,850,179
+12.9%
596,192
-9.3%
0.44%
+4.3%
Q3 2022$29,107,000
-15.0%
657,188
-6.4%
0.42%
-13.6%
Q2 2022$34,240,000
+463.3%
702,068
+461.8%
0.48%
+581.7%
Q1 2022$6,079,000
+17.7%
124,961
+3.1%
0.07%
+34.0%
Q4 2021$5,166,000
+4.2%
121,161
-6.3%
0.05%
+6.0%
Q3 2021$4,956,000129,2890.05%
Other shareholders
HARMONY BIOSCIENCES HLDGS IN shareholders Q2 2023
NameSharesValueWeighting ↓
Valor Management LLC 11,218,033$367,614,94198.94%
Nan Fung Group Holdings Ltd 368,665$12,081,1529.78%
venBio Partners LLC 1,035,396$33,929,9279.62%
Vivo Capital, LLC 2,606,247$85,406,7149.36%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 314,500$10,306,1653.47%
AlphaCentric Advisors LLC 122,000$3,997,9402.27%
ASHFORD CAPITAL MANAGEMENT INC 434,148$14,227,0302.09%
Altium Capital Management LP 117,000$3,834,0902.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 595,490$19,514,2071.90%
TANG CAPITAL MANAGEMENT LLC 271,200$8,887,2241.25%
View complete list of HARMONY BIOSCIENCES HLDGS IN shareholders